应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
R 瑞德系统
交易中 05-01 10:29:13 EDT
252.76
-1.01
-0.40%
最高
258.49
最低
252.01
成交量
6.04万
今开
257.73
昨收
253.77
日振幅
2.55%
总市值
97.80亿
流通市值
94.25亿
总股本
3,869万
成交额
1,535万
换手率
0.16%
流通股本
3,729万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
瑞德系统获准启动股票回购计划 2026年5月起两年内最多回购200万股普通股
美股速递 · 18:56
瑞德系统获准启动股票回购计划 2026年5月起两年内最多回购200万股普通股
Matrix Service Company宣布首席财务官职务交接计划
投资观察 · 04:13
Matrix Service Company宣布首席财务官职务交接计划
OPKO Health扩大与Nicoya合作协议 加速RAYALDEE(R)在大中华区商业化进程
投资观察 · 04-30 20:32
OPKO Health扩大与Nicoya合作协议 加速RAYALDEE(R)在大中华区商业化进程
加州水务服务集团董事会宣布连续第325次派发季度股息
投资观察 · 04-30 04:08
加州水务服务集团董事会宣布连续第325次派发季度股息
Fulcrum Therapeutics任命Josh Lehrer加入董事会
投资观察 · 04-27
Fulcrum Therapeutics任命Josh Lehrer加入董事会
Reeds任命达米安·瓦舍尔为首席运营官
投资观察 · 04-25
Reeds任命达米安·瓦舍尔为首席运营官
异动解读 | 瑞德系统盘中大涨5.15%,因上调盈利预期及战略举措显效
异动解读 · 04-23
异动解读 | 瑞德系统盘中大涨5.15%,因上调盈利预期及战略举措显效
瑞德系统上调2026年每股收益预期区间 反映二手车市场状况温和改善预期
美股速递 · 04-23
瑞德系统上调2026年每股收益预期区间 反映二手车市场状况温和改善预期
瑞德系统公司战略举措显效 2026年盈利增长路径明确 7000万美元增量效益助推业绩
美股速递 · 04-23
瑞德系统公司战略举措显效 2026年盈利增长路径明确 7000万美元增量效益助推业绩
玉生物科学任命爱德华·R·康纳博士为首席医疗官
投资观察 · 04-22
玉生物科学任命爱德华·R·康纳博士为首席医疗官
新闻稿:Scotts Miracle-Gro公司宣布季度股息派发
投资观察 · 04-21
新闻稿:Scotts Miracle-Gro公司宣布季度股息派发
Eton Pharmaceuticals公布首席财务官继任计划
投资观察 · 04-16
Eton Pharmaceuticals公布首席财务官继任计划
财报前瞻|瑞德系统营收预计小幅下滑,EPS或同比回落
财报Agent · 04-16
财报前瞻|瑞德系统营收预计小幅下滑,EPS或同比回落
Byrna科技擢升马修·坎帕尼为首席战略官
投资观察 · 04-15
Byrna科技擢升马修·坎帕尼为首席战略官
Structure Therapeutics任命Matthew Lang为首席运营官兼总法律顾问
投资观察 · 04-15
Structure Therapeutics任命Matthew Lang为首席运营官兼总法律顾问
杰龙公司宣布任命蒂莫西·威廉姆斯为执行副总裁、首席法务官兼公司秘书
投资观察 · 04-13
杰龙公司宣布任命蒂莫西·威廉姆斯为执行副总裁、首席法务官兼公司秘书
NewtekOne公司偿还并预计终止控股子公司循环信贷额度
投资观察 · 04-10
NewtekOne公司偿还并预计终止控股子公司循环信贷额度
联合锂业金属公司更新Kwyjibo稀土项目进展
投资观察 · 04-08
联合锂业金属公司更新Kwyjibo稀土项目进展
临床阶段生物制药公司Avalyn任命资深高管Jon Congleton加入董事会
投资观察 · 04-06
临床阶段生物制药公司Avalyn任命资深高管Jon Congleton加入董事会
BioCryst制药任命Sandeep M. Menon为首席研发官
投资观察 · 04-06
BioCryst制药任命Sandeep M. Menon为首席研发官
加载更多
公司概况
公司名称:
瑞德系统
所属市场:
NYSE
上市日期:
--
主营业务:
莱德系统公司是一家成立于1933年的佛罗里达州企业,是全球领先的运输和供应链管理解决方案提供商。该公司提供从港口到门的全流程解决方案,整合供应链的各个环节,包括国际入境物流和跨境物流、车队和运输管理、仓储、制造支持以及多渠道最终交付。其互补的业务板块提供广泛的增值解决方案,为客户打造无缝衔接的端到端物流网络,旨在降低复杂性,并提升整个货物流转的速度、可靠性和效率。
发行价格:
--
{"stockData":{"symbol":"R","market":"US","secType":"STK","nameCN":"瑞德系统","latestPrice":252.76,"timestamp":1777645752588,"preClose":253.77,"halted":0,"volume":60408,"delay":0,"changeRate":-0.00397998187334996,"floatShares":37289800,"shares":38691000,"eps":12.049,"marketStatus":"交易中","change":-1.01,"latestTime":"05-01 10:29:13 EDT","open":257.73,"high":258.485,"low":252.0061,"amount":15348599.34984,"amplitude":0.025531,"askPrice":253.13,"askSize":2,"bidPrice":252.12,"bidSize":124,"shortable":3,"etf":0,"ttmEps":12.049,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1777665600000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":-292968000000,"exchange":"NYSE","adjPreClose":253.77,"dividendRate":0.014016,"preHourTrading":{"tag":"盘前","latestPrice":258.4197,"preClose":253.77,"latestTime":"07:03 EDT","volume":4,"amount":1019.72972,"timestamp":1777633385343,"change":4.6497,"changeRate":0.018322,"amplitude":0.018322},"postHourTrading":{"tag":"盘后","latestPrice":253.77,"preClose":253.77,"latestTime":"19:54 EDT","volume":14858,"amount":3770580.2,"timestamp":1777593294685,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.737224,"impliedVol":0.3552,"impliedVolPercentile":0.5219},"requestUrl":"/m/hq/s/R","defaultTab":"news","newsList":[{"id":"1132935585","title":"瑞德系统获准启动股票回购计划 2026年5月起两年内最多回购200万股普通股","url":"https://stock-news.laohu8.com/highlight/detail?id=1132935585","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1132935585?lang=zh_cn&edition=full","pubTime":"2026-05-01 18:56","pubTimestamp":1777632976,"startTime":"0","endTime":"0","summary":"瑞德系统公司近日宣布,董事会已批准一项股票回购授权,允许公司在2026年5月1日至2028年5月1日的两年期间,回购最多200万股普通股。\n此项回购计划彰显了管理层对公司长期发展前景的信心,同时也体现了公司致力于通过资本回报提升股东价值的承诺。根据授权条款,回购可通过公开市场交易或私募方式进行,具体实施将视市场状况和公司现金流情况而定。\n股票回购作为企业资本配置的重要工具,往往被市场视为积极信号。分析人士指出,此举有望优化公司股本结构,并对每股收益产生正向影响。瑞德系统此次回购规模与实施周期,反映出其稳健的财务策略和对未来业务增长的乐观预期。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["R","BK4022","BK4232"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143879637","title":"Matrix Service Company宣布首席财务官职务交接计划","url":"https://stock-news.laohu8.com/highlight/detail?id=1143879637","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1143879637?lang=zh_cn&edition=full","pubTime":"2026-05-01 04:13","pubTimestamp":1777580003,"startTime":"0","endTime":"0","summary":"俄克拉荷马州塔尔萨,2026年4月30日——能源与工业市场领先的工程建筑服务商Matrix Service Company今日宣布,财务副总裁兼首席财务官Kevin Cavanah将在公司提交2026财年年度报告后卸任。在此之前,他将继续履行首席财务官职责,确保职务交接平稳有序。目前公司已聘请顶尖高管猎头机构,全面启动下任首席财务官的遴选工作。\"感谢Kevin过去23年间为Matrix作出的领导贡献与服务。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4022","BK4129","R","BK4232","MTRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163720206","title":"OPKO Health扩大与Nicoya合作协议 加速RAYALDEE(R)在大中华区商业化进程","url":"https://stock-news.laohu8.com/highlight/detail?id=1163720206","media":"投资观察","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1163720206?lang=zh_cn&edition=full","pubTime":"2026-04-30 20:32","pubTimestamp":1777552347,"startTime":"0","endTime":"0","summary":"迈阿密2026年4月30日电——OPKO Health, Inc.今日宣布其子公司EirGen Pharma Limited已与Nicoya Therapeutics 有限公司签署协议修正案。该协议授予OPKO获得Nicoya Therapeutics的股权,并进一步强化了Nicoya在大中华区商业化RAYALDEE的承诺。目前RAYALDEE已在澳门获得批准,双方预计将于2027年在中国及相关区域取得监管批准。根据修订后的协议条款,OPKO通过调整分层特许权使用费和转让价格方案,获得了Nicoya公司15%的股权。此次修订在扩大适用范围的同时,进一步巩固了Nicoya在大中华区推广RAYALDEE的承诺。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4232","R","BK4139","BK4022","BK4196","OPK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139680104","title":"加州水务服务集团董事会宣布连续第325次派发季度股息","url":"https://stock-news.laohu8.com/highlight/detail?id=1139680104","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1139680104?lang=zh_cn&edition=full","pubTime":"2026-04-30 04:08","pubTimestamp":1777493299,"startTime":"0","endTime":"0","summary":"加州圣何塞——加州水务服务集团董事会于2026年4月29日举行的会议上,宣布派发公司连续第325次季度股息,每股普通股派息0.3350美元。此次股息将于2026年5月22日支付给在2026年5月11日营业时间结束前登记在册的股东。本新闻稿中前瞻性陈述的示例包括但不限于描述季度股息支付预期时间的陈述。我们没有任何义务,并明确声明无任何义务,因新信息、未来事件或其他原因而更新或修改任何前瞻性陈述。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4232","BK4172","BK4022","CWT","R"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182566662","title":"Fulcrum Therapeutics任命Josh Lehrer加入董事会","url":"https://stock-news.laohu8.com/highlight/detail?id=1182566662","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1182566662?lang=zh_cn&edition=full","pubTime":"2026-04-27 18:58","pubTimestamp":1777287509,"startTime":"0","endTime":"0","summary":"马萨诸塞州剑桥,2026年4月27日——临床阶段生物制药公司Fulcrum Therapeutics今日宣布,任命医学博士、哲学硕士、美国心脏病学院院士Josh Lehrer为其董事会独立董事。他现任临床阶段生物技术公司Marea Therapeutics的首席执行官兼董事会成员。Fulcrum Therapeutics是一家临床阶段生物制药公司,致力于研发改善罕见血液疾病患者生活的小分子药物。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["R","BK4007","FULC","BK4232","BK4022","SCD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185466095","title":"Reeds任命达米安·瓦舍尔为首席运营官","url":"https://stock-news.laohu8.com/highlight/detail?id=1185466095","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1185466095?lang=zh_cn&edition=full","pubTime":"2026-04-25 04:06","pubTimestamp":1777061214,"startTime":"0","endTime":"0","summary":"诺沃克,2026年4月24日——全美领先手工天然姜汁饮料组合的所有者Reeds公司今日宣布,任命达米安·瓦舍尔为首席运营官,该任命自2026年4月27日起生效。瓦舍尔先生是一位经验丰富的消费品运营高管,在扩展饮料制造业务、提升供应链效率以及推动复杂组织盈利增长方面拥有深厚专长。瓦舍尔先生与Reeds早有渊源,曾担任公司运营副总裁。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4177","BK4232","REED","BK4022","R"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156021810","title":"异动解读 | 瑞德系统盘中大涨5.15%,因上调盈利预期及战略举措显效","url":"https://stock-news.laohu8.com/highlight/detail?id=1156021810","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1156021810?lang=zh_cn&edition=full","pubTime":"2026-04-23 22:54","pubTimestamp":1776956076,"startTime":"0","endTime":"0","summary":"瑞德系统(R)今日盘中股价大幅上涨5.15%,引起了市场的广泛关注。消息面上,公司今日早间宣布上调其2026年每股收益预期区间,这主要基于对二手车交易环境逐步回暖的乐观判断。同时,公司表示其战略举措正显成效,预计将带来7000万美元的增量效益,为2026年的盈利增长明确了路径。管理层指出,商用车辆二手交易市场的供需关系正在重新平衡,有望为公司租赁业务带来更稳定的收益。通过供应链优化和车队管理数字化等关键举措,公司正逐步释放潜在价值,增强了投资者对其未来业绩的信心。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["R"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167210944","title":"瑞德系统上调2026年每股收益预期区间 反映二手车市场状况温和改善预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1167210944","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1167210944?lang=zh_cn&edition=full","pubTime":"2026-04-23 19:00","pubTimestamp":1776942020,"startTime":"0","endTime":"0","summary":"瑞德系统宣布调整其2026年财务指引,将每股收益预测区间进行上调。此次修正主要基于公司对二手车交易环境逐步回暖的乐观判断,预计市场条件将呈现适度向好趋势。\n管理层在最新展望中指出,商用车辆二手交易市场的供需关系正在重新平衡,这一积极变化有望为公司的租赁业务板块带来更稳定的收益基础。通过对行业周期走势的精准预判,瑞德系统主动优化盈利指标,展现出对核心业务韧性的信心。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4022","BK4232","R"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195418053","title":"瑞德系统公司战略举措显效 2026年盈利增长路径明确 7000万美元增量效益助推业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=1195418053","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1195418053?lang=zh_cn&edition=full","pubTime":"2026-04-23 18:57","pubTimestamp":1776941879,"startTime":"0","endTime":"0","summary":"瑞德系统公司正稳步迈向2026年的盈利增长目标,其核心驱动力来自于战略举措带来的7000万美元增量效益正在高效落地。这一积极态势凸显了公司战略转型的前瞻性与执行力。\n通过精准推进供应链优化、车队管理数字化等关键举措,公司逐步释放潜在价值。管理层对实现既定财务目标展现出强烈信心,市场分析师亦密切关注其战略红利持续兑现的进程。\n在当前复杂的经济环境下,瑞德系统凭借清晰的战略路径和稳健的运营能力,为中长期盈利增长奠定了坚实基础。投资者可期待其通过精细化运营与技术创新双轮驱动,持续提升企业价值。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4232","R","BK4022"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151902012","title":"玉生物科学任命爱德华·R·康纳博士为首席医疗官","url":"https://stock-news.laohu8.com/highlight/detail?id=1151902012","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1151902012?lang=zh_cn&edition=full","pubTime":"2026-04-22 19:05","pubTimestamp":1776855940,"startTime":"0","endTime":"0","summary":"临床阶段生物技术公司玉生物科学今日宣布,任命医学博士爱德华·R·康纳为公司首席医疗官,此项任命自即日起生效。康纳博士在加入玉生物科学之前,曾任职于Ardelyx公司,担任首席医疗官。玉生物科学是一家临床阶段的生物技术公司,专注于开发针对自身免疫性疾病关键未满足需求的同类最佳疗法。公司的领先候选药物JADE101靶向细胞因子APRIL,目前正在评估用于治疗免疫球蛋白A肾病。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["R","BK4232","BK4139","BK4539","BK4022","JBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117391150","title":"新闻稿:Scotts Miracle-Gro公司宣布季度股息派发","url":"https://stock-news.laohu8.com/highlight/detail?id=1117391150","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1117391150?lang=zh_cn&edition=full","pubTime":"2026-04-21 04:08","pubTimestamp":1776715689,"startTime":"0","endTime":"0","summary":"俄亥俄州玛丽斯维尔,2026年4月20日——北美品牌消费草坪和园艺产品领先营销商Scotts Miracle-Gro公司宣布,其董事会已批准派发每股0.66美元的现金股息。该股息将于2026年6月5日(星期五)派发给截至2026年5月22日(星期五)登记在册的股东。其旗下品牌在业内享有极高知名度,其中Scotts、Miracle-Gro、Ortho和Tomcat品牌在各自品类中均处于市场领先地位。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4232","BK4093","SMG","BK4022","LU1878469433.USD","R"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158617122","title":"Eton Pharmaceuticals公布首席财务官继任计划","url":"https://stock-news.laohu8.com/highlight/detail?id=1158617122","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1158617122?lang=zh_cn&edition=full","pubTime":"2026-04-16 18:52","pubTimestamp":1776336736,"startTime":"0","endTime":"0","summary":"伊利诺伊州迪尔帕克,2026年4月16日——专注于罕见病治疗药物研发与商业化的创新制药公司Eton Pharmaceuticals, Inc.今日宣布,任命朱迪丝·M·马修斯为执行副总裁,主管会计与财务。马修斯女士将于2026年6月1日正式出任公司首席财务官。公司现任首席财务官詹姆斯·格鲁伯将按既定继任计划卸任。Eton Pharmaceuticals首席执行官肖恩·布林杰尔森表示:\"我们热烈欢迎朱迪加入Eton。在加入Eton之前,她于2015年至2026年期间担任Iterum Therapeutics plc的首席财务官。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["R","BK4007","ETON","BK4604","BK4099","BK4555","TM","BK4022","BK4232","BK4585","03160","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162443989","title":"财报前瞻|瑞德系统营收预计小幅下滑,EPS或同比回落","url":"https://stock-news.laohu8.com/highlight/detail?id=1162443989","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1162443989?lang=zh_cn&edition=full","pubTime":"2026-04-16 10:26","pubTimestamp":1776306389,"startTime":"0","endTime":"0","summary":"瑞德系统将于2026年04月23日美股盘前发布最新季度财报,市场关注收入与每股收益的同比变化及利润率走向。市场一致预期本季度瑞德系统营收为31.39亿美元,同比下降0.28%;调整后每股收益为2.27美元,同比下降5.48%;息税前利润为2.12亿美元,同比下降5.56%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"财报前瞻|瑞德系统营收预计小幅下滑,EPS或同比回落","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["R"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170169725","title":"Byrna科技擢升马修·坎帕尼为首席战略官","url":"https://stock-news.laohu8.com/highlight/detail?id=1170169725","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1170169725?lang=zh_cn&edition=full","pubTime":"2026-04-15 20:05","pubTimestamp":1776254759,"startTime":"0","endTime":"0","summary":"马萨诸塞州安多弗——专注于研发、制造和销售创新型非致命个人安全解决方案的个人防卫技术公司Byrna Technologies Inc.近日宣布,马修·坎帕尼晋升为公司首席战略官。履新后,坎帕尼将主导公司的战略规划计划,并支持跨职能部门的执行工作,助力Byrna持续扩展业务规模,为下一阶段的增长做好准备。该公司是Byrna CL、Byrna LE和Byrna SD个人安全装置的制造商,这些先进的手持式二氧化碳动力发射器旨在为消费者、私人安保和执法市场提供一种非致命的枪支替代品。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["R","BK4232","BK4022","RMP","BYRN","BK4187"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115849765","title":"Structure Therapeutics任命Matthew Lang为首席运营官兼总法律顾问","url":"https://stock-news.laohu8.com/highlight/detail?id=1115849765","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1115849765?lang=zh_cn&edition=full","pubTime":"2026-04-15 04:07","pubTimestamp":1776197275,"startTime":"0","endTime":"0","summary":"旧金山,2026年4月14日——临床阶段全球生物制药公司Structure Therapeutics Inc.今日宣布,任命Matthew Lang, J.D. 为公司首席运营官兼总法律顾问。Lang先生在加入Structure Therapeutics时,已在全球生物制药机构拥有超过十五年的高管领导经验,其深厚专长涵盖法律、企业战略、合规、风险管理和业务发展等多个领域。Structure Therapeutics首席执行官Raymond Stevens博士表示:\"Matt是一位经验丰富的领导者,在引导组织实现增长和转型方面拥有卓越的业绩记录。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4022","BK4539","R","BK4232","BK4007","GPCR","BK4599","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104133040","title":"杰龙公司宣布任命蒂莫西·威廉姆斯为执行副总裁、首席法务官兼公司秘书","url":"https://stock-news.laohu8.com/highlight/detail?id=1104133040","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1104133040?lang=zh_cn&edition=full","pubTime":"2026-04-13 20:01","pubTimestamp":1776081718,"startTime":"0","endTime":"0","summary":"加利福尼亚州福斯特城,2026年4月13日——处于商业化阶段的生物制药企业杰龙公司今日宣布,任命蒂莫西·威廉姆斯为执行副总裁、首席法务官兼公司秘书。该公司致力于通过改变血癌的治疗进程来改善患者生活。蒂莫西·威廉姆斯于2018年至2026年3月期间,在Vanda Pharmaceuticals担任高级副总裁、总法律顾问兼秘书。除法律要求外,杰龙公司不承担任何更新这些前瞻性陈述以反映未来信息、事件或情况的义务。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765489.SGD","LU0345780950.USD","GERN","IE00BMG7P587.USD","LU1621767737.EUR","WMB","LU0070302665.USD","LU2237443382.USD","LU0300736492.USD","LU2237443978.SGD","LU2384288077.EUR","LU0630314457.HKD","LU0208291251.USD","LU2237443622.USD","LU2463526074.USD","IE00BMG7P819.SGD","LU2237443895.HKD","BK4585","LU0456854461.SGD","BK4022","LU1621768206.USD","LU1621767810.EUR","IE00BLSP4452.SGD","LU2237443465.HKD","BK4139","R","SG9999002521.SGD","IE00BBT3K403.USD","IE00BMG7P702.HKD","LU0788109394.HKD","IE00BLSP4239.USD","BK4232","LU0122376428.USD","LU1621768115.EUR","IE00BMG7P926.USD","LU0266512473.USD","IE00BMG7P694.USD","LU0300736062.USD","LU2237443549.SGD","LU0266512127.USD","BK4144","BK4588","IE00BN8TJ469.HKD","LU0345781412.USD","LU0368265418.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199025777","title":"NewtekOne公司偿还并预计终止控股子公司循环信贷额度","url":"https://stock-news.laohu8.com/highlight/detail?id=1199025777","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1199025777?lang=zh_cn&edition=full","pubTime":"2026-04-10 20:32","pubTimestamp":1775824365,"startTime":"0","endTime":"0","summary":"2026年4月10日,NewtekOne公司宣布其子公司Newtek ALP Holdings已全额偿还两项用于替代贷款计划发放的信贷额度。未来,该公司的银行子公司Newtek Bank将直接通过存款资金开展此类贷款的发放业务。自2019年启动该业务以来,NewtekOne持续通过资产证券化方式处理工商业长期摊销贷款,并计划后续直接从银行资产负债表进行证券化操作。Newtek ALP Holdings已于3月结清并终止与第一资本的信贷协议,预计将在4月底前终止与德意志银行的信贷安排。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0053666078.USD","BK4585","BK4184","LU0130517989.USD","LU0980610538.SGD","BK4022","LU0683600562.USD","LU0477156953.USD","BK4588","LU0648000940.SGD","NEWT","BK4516","COF","LU1861217088.USD","LU2108987350.USD","LU0648001328.SGD","LU1668664300.SGD","LU1074936037.SGD","LU0130102774.USD","BK4232","R","LU1201861249.SGD","LU1791807156.HKD","LU2360107671.USD","BK4135","LU0477156797.USD","IE000M9KFDE8.USD","LU0211331839.USD","LU1861220207.SGD","LU1323610961.USD","IE00B19Z3581.USD","IE00BFXG1179.USD","LU1201861165.SGD","IE0002270589.USD","LU0210528500.USD","BK4166","LU0130518102.USD","LU0130103400.USD","LU0787776722.HKD","LU2487616109.SGD","IE00B19Z3B42.SGD","LU0106831901.USD","BK4559"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141921954","title":"联合锂业金属公司更新Kwyjibo稀土项目进展","url":"https://stock-news.laohu8.com/highlight/detail?id=1141921954","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1141921954?lang=zh_cn&edition=full","pubTime":"2026-04-08 07:34","pubTimestamp":1775604891,"startTime":"0","endTime":"0","summary":"多伦多,2026年4月7日——联合锂业金属公司欣然宣布,公司已获得魁北克省北岸地区塞提尔市东北125公里处Kwyjibo稀土项目的收购期权。该期权允许公司在满足特定条件后,最高可获得项目80%的不可分割权益。公司正全力编制项目技术报告,该报告是多伦多创业板交易所在有条件批准函中规定的交割条件之一。有关此次收购的详细内容,可查阅公司于2025年11月18日及2026年2月5日发布的新闻稿,相关文件已在SEDAR+网站www.sedarplus.ca的CLM企业档案中公开。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4115","BK4022","LIT","BK4535","BK4168","CNSL","PICK","SETM","JORFF","BK4588","R","BK4232","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131655875","title":"临床阶段生物制药公司Avalyn任命资深高管Jon Congleton加入董事会","url":"https://stock-news.laohu8.com/highlight/detail?id=1131655875","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1131655875?lang=zh_cn&edition=full","pubTime":"2026-04-06 20:03","pubTimestamp":1775477002,"startTime":"0","endTime":"0","summary":"波士顿,2026年4月6日——临床阶段生物制药公司Avalyn Pharma Inc.今日宣布,任命成就卓著的生物制药高管Jon Congleton加入其董事会。Avalyn专注于开发吸入疗法,旨在彻底改变严重罕见呼吸系统疾病的治疗模式。Congleton先生目前担任Mineralys Therapeutics, Inc.的首席执行官兼董事会成员,他带领该公司从一家私有的早期机构,发展成为一家公开上市、处于商业化前阶段的生物技术公司。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4232","R","BK4022"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105528475","title":"BioCryst制药任命Sandeep M. Menon为首席研发官","url":"https://stock-news.laohu8.com/highlight/detail?id=1105528475","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1105528475?lang=zh_cn&edition=full","pubTime":"2026-04-06 19:04","pubTimestamp":1775473445,"startTime":"0","endTime":"0","summary":"经验丰富的研发领导者Sandeep M. Menon博士加入BioCryst制药,其职业生涯以推动创新疗法从早期开发走向全球获批而著称。BioCryst制药近日宣布,任命医学博士、哲学博士Sandeep M. Menon为首席研发官。凭借ORLADEYO的商业成功,以及近期对Astria Therapeutics及其navenibart项目的收购,BioCryst正步入战略执行的新阶段,旨在通过罕见病疗法的开发和商业化来构建价值。Menon博士从Alnylam制药公司加入BioCryst,此前他在该公司担任首席开发官,负责监督跨越多个治疗领域的广泛产品组合的全球临床开发与安全事务。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","R","ICON","BK4585","BK4547","BK4604","BK4099","BK4555","TM","BK4022","BK4232","BK4021","03160","BCRX","BK4588"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ryder.com;investors.ryder.com","stockEarnings":[{"period":"1week","weight":0.0461},{"period":"1month","weight":0.2397},{"period":"3month","weight":0.3267},{"period":"6month","weight":0.4996},{"period":"1year","weight":0.8433},{"period":"ytd","weight":0.3259}],"compareEarnings":[{"period":"1week","weight":0.0144},{"period":"1month","weight":0.1051},{"period":"3month","weight":0.0386},{"period":"6month","weight":0.0537},{"period":"1year","weight":0.296},{"period":"ytd","weight":0.0539}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"莱德系统公司是一家成立于1933年的佛罗里达州企业,是全球领先的运输和供应链管理解决方案提供商。该公司提供从港口到门的全流程解决方案,整合供应链的各个环节,包括国际入境物流和跨境物流、车队和运输管理、仓储、制造支持以及多渠道最终交付。其互补的业务板块提供广泛的增值解决方案,为客户打造无缝衔接的端到端物流网络,旨在降低复杂性,并提升整个货物流转的速度、可靠性和效率。","yearOnYearQuotes":[{"month":1,"riseRate":0.586957,"avgChangeRate":0.019416},{"month":2,"riseRate":0.586957,"avgChangeRate":0.011618},{"month":3,"riseRate":0.565217,"avgChangeRate":0.006717},{"month":4,"riseRate":0.531915,"avgChangeRate":0.02614},{"month":5,"riseRate":0.543478,"avgChangeRate":0.00898},{"month":6,"riseRate":0.456522,"avgChangeRate":0.001539},{"month":7,"riseRate":0.608696,"avgChangeRate":0.03247},{"month":8,"riseRate":0.434783,"avgChangeRate":-0.006824},{"month":9,"riseRate":0.521739,"avgChangeRate":-0.006569},{"month":10,"riseRate":0.543478,"avgChangeRate":0.00111},{"month":11,"riseRate":0.630435,"avgChangeRate":0.027401},{"month":12,"riseRate":0.543478,"avgChangeRate":0.009358}],"exchange":"NYSE","name":"瑞德系统","nameEN":"Ryder"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"瑞德系统(R)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供瑞德系统(R)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"瑞德系统,R,瑞德系统股票,瑞德系统股票老虎,瑞德系统股票老虎国际,瑞德系统行情,瑞德系统股票行情,瑞德系统股价,瑞德系统股市,瑞德系统股票价格,瑞德系统股票交易,瑞德系统股票购买,瑞德系统股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"瑞德系统(R)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供瑞德系统(R)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}